Literatur
-
1
Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
J Natl Cancer Inst.
2000;
92
397-402
-
2
Birner P, Schindl M, Stani J, Oberhuber G, Czerwenka K, Vutuc C, Breitenecker G.
Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology.
Klein Wochenschr Wien.
2000;
112
761-766
-
3
Bosch F X, Manos M M, Munoz N, Sherman M, Jansen A M, Peto J, Schiffman M H, Moreno V, Kurman R, Shah K V.
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group [see comments].
J Natl Cancer Inst.
1995;
87
796-802
-
4
Brisson J, Bairati I, Morin C, Fortier M, Bouchard C, Christen A, Bernard P, Roy M, Meisels A.
Determinants of persistent detection of human papillomavirus DNA in the uterine cervix.
J Infect Dis.
1996;
173
794-799
-
5
Cope J U, Hildesheim A, Schiffman M H, Manos M M, Lorincz A T, Burk R D, Glass A G, Greer C, Buckland J, Helgesen K, Scott D R, Sherman M E, Kurman R J, Liaw K L.
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
J Clin Microbiol.
1997;
35
2262-2265
-
6
Dew J E, Athanasatos P, Hacker N F.
The significance of mild squamous atypia on cytology [see comments].
Aust N Z J Obstet Gynaecol.
1995;
35
443-445
-
7
Di Lonardo A, Marcante M L, Poggiali F, Venuti A.
HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment.
J Med Virol.
1998;
54
192-195
-
8
Gullotta G, Margariti P A, Rabitti C, Balsamo G, Valle D, Capelli A, Mancuso S.
Cytology, histology, and colposcopy in the diagnosis of neoplastic non- invasive epithelial lesions of the cervix.
Eur J Gynaecol Oncol.
1997;
18
36-38
-
9
Helland A, Karlsen F, Due E U, Holm R, Kristensen G, Borresen-Dale A l.
Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Br J Cancer.
1998;
78
69-72
-
10
Hermonat P L, Plott R T, Santin A D, Parham G P, Flick J T.
Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16- ras chimeric.
Gynecol Oncol.
1997;
66
487-494
-
11
Hernadi Z, Sapy T, Konya J, Veress G, Czegledy J.
[Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix].
Orv Hetil.
1997;
138
1249-1253
-
12
Hinchliffe S A, van Velzen D, Korporaal H, Kok P L, Boon M E.
Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology.
Br J Cancer.
1995;
72
943-945
-
13
Ho G Y, Burk R D, Klein S, Kadish A S, Chang C J, Palan P, Basu J, Tachezy R, Lewis R, Romney S.
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia [see comments].
J Natl Cancer Inst.
1995;
87
1365-1371
-
14
Macgregor J, Campbell M K, Mann E MF, Swanson K Y.
Screening for cervical intraepithelial neoplasia in north east scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
British Medical Journal.
1994;
308
1407-1411
-
15
Mitchell H, Higgins V.
Recent negative cytology prior to histologically confirmed carcinoma in situ of the cervix.
Aust N Z J Obstet Gynaecol.
1994;
34
178-181
-
16
Nindl I, Lörincz A, Mielzynska I, Petry K U, Baur S, Kirchmayr R, Michels W, Schneider A.
Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen methods.
Clinical and Diagnostic Virology.
1998;
10
49-56
-
17
Nobbenhuis M A, Walboomers J M, Helmerhorst T J, Rozendaal L, Remmink A J, Risse E K, van der Linden H C, Voorhorst F J, Kenemans P, Meijer C J.
Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.
Lancet.
1999;
354
20-25
-
18
O'Leary J J, Landers R J, Crowley M, Healy I, O'Donovan M, Healy V, Kealy W F, Hogan J, Doyle C T.
Human papillomavirus and mixed epithelial tumors of the endometrium [see comments].
Hum Pathol.
1998;
29
383-389
-
19
Peyton C L, Schiffman M, Lorincz A T, Hunt W C, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera L A, Rodriguez A C, Herrero R, Sherman M E, Wheeler C M.
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
J Clin Microbiol.
1998;
36
3248-3254
-
20
Sasagawa T, Dong Y, Saijoh K, Satake S, Tateno M, Inoue M.
Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan.
Jpn J Cancer Res.
1997;
88
376-384
-
21
Sherman M E, Kurman R J.
The role of exfoliative cytology and histopathology in screening and triage.
Obstet Gynecol Clin North Am.
1996;
23
641-655
-
22
Sodhani P, Singh V, Das D K, Bhambhani S.
Cytohistological correlation as a measure of quality assurance of a cytology laboratory [see comments].
Cytopathology.
1998;
8
103-107
-
23
Solomon D, Schiffman M, Tarone R.
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
J Natl Cancer Inst.
2001;
93
293-299
-
24
Sotlar K, Selinka H C, Menton M, Kandolf R, Bultmann B.
Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR.
Gynecol Oncol.
1998;
69
114-121
-
25
Svare E I, Kjaer S K, Worm A M, Osterlind A, Moi H, Christensen R B, Meijer C J, Walboomers J M, van den Brule A J.
Risk factors for hpv infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence.
Int J Cancer.
1998;
75
1-8
-
26
Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A.
Detection of high-risk HPV types by the hybrid capture 2 test.
J Med Virol.
2001;
65
155-162
-
27
Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H.
Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Gynecol Oncol.
1997;
65
23-29
-
28
van den Brule A JC, Walboomers J MM, du Maine M, Kenemans C JL, Meijer C JLM.
Difference in prevalenceof human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia.
Int J Cancer.
1991;
48
404-408
-
29
Venuti A, Badaracco G, Sedati A, Carbini R, Marcante M L.
Determinants of human papillomavirus types 16 and 18 infections in the lower female genital tract in an Italian population.
Eur J Gynaecol Oncol.
1994;
15
205-210
-
30
Walboomers J MM, Jacobs M V, Manos M M, Bosch F X, Kummer A, Hhah K V, Snijder P JF, Peto J, Meijer C h, Munoz N.
Human Papillomavirus is a necessary cause of invasive Cervical cancer worldwide.
J Pathol.
1999;
189
12-19
Dr. Gerd Böhmer
Frauenklinik der Medizinischen Hochschule Hannover
Oststadtkrankenhaus
Podbielskistraße 380
30659 Hannover
Phone: 05 11/9 06 37 05
Fax: 05 11/9 06 33 37
Email: gboehmer@gmx.net
